A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany
Abstract Background: A total of 62/66 (93.9%) residents in a senior citizen home in Bremen, Germany, received the first dose of the Biontech/Pfizer vaccine BNT162b2 on December 27th 2020. After routine severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antigen tests showed positive results...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d4c59a316a74985af8e11064f6b7dd4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9d4c59a316a74985af8e11064f6b7dd4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9d4c59a316a74985af8e11064f6b7dd42021-11-12T19:57:15ZA single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany2050-452710.1002/iid3.532https://doaj.org/article/9d4c59a316a74985af8e11064f6b7dd42021-12-01T00:00:00Zhttps://doi.org/10.1002/iid3.532https://doaj.org/toc/2050-4527Abstract Background: A total of 62/66 (93.9%) residents in a senior citizen home in Bremen, Germany, received the first dose of the Biontech/Pfizer vaccine BNT162b2 on December 27th 2020. After routine severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antigen tests showed positive results on January 5th, all residents and staff were tested by RT‐PCR. Results: Nine staff members and 23 residents had a positive result. PCR positive staff members reported mild to severe COVID‐19 symptoms, one was hospitalized. None of them had been vaccinated. In contrast, the vaccinated residents reported no or only mild symptoms. Sequencing of the SARS‐CoV‐2 genomes of infected individuals revealed a monophyletic origin of the outbreak within the PANGO lineage B.1.177.86. Conclusions: In summary, our data show that partial vaccination prevented severe COVID‐19 among the residents during this local SARS‐CoV‐2 outbreak, suggesting a high effectiveness of even a single vaccine dose, but also emphasize that asymptomatic individuals might still be carriers/spreaders.Rolf SchwarzerSabine D. FreysNick NeuwingerNina BeikertBettina EberspächerAnke EdelmannMarta ZuchowskiInga SlothouwerAngela SteinKathrin TheilPeter MenzelJörg HofmannWileyarticleinfectionsprocessesvaccinationviral/retroviralImmunologic diseases. AllergyRC581-607ENImmunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1809-1814 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
infections processes vaccination viral/retroviral Immunologic diseases. Allergy RC581-607 |
spellingShingle |
infections processes vaccination viral/retroviral Immunologic diseases. Allergy RC581-607 Rolf Schwarzer Sabine D. Freys Nick Neuwinger Nina Beikert Bettina Eberspächer Anke Edelmann Marta Zuchowski Inga Slothouwer Angela Stein Kathrin Theil Peter Menzel Jörg Hofmann A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany |
description |
Abstract Background: A total of 62/66 (93.9%) residents in a senior citizen home in Bremen, Germany, received the first dose of the Biontech/Pfizer vaccine BNT162b2 on December 27th 2020. After routine severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antigen tests showed positive results on January 5th, all residents and staff were tested by RT‐PCR. Results: Nine staff members and 23 residents had a positive result. PCR positive staff members reported mild to severe COVID‐19 symptoms, one was hospitalized. None of them had been vaccinated. In contrast, the vaccinated residents reported no or only mild symptoms. Sequencing of the SARS‐CoV‐2 genomes of infected individuals revealed a monophyletic origin of the outbreak within the PANGO lineage B.1.177.86. Conclusions: In summary, our data show that partial vaccination prevented severe COVID‐19 among the residents during this local SARS‐CoV‐2 outbreak, suggesting a high effectiveness of even a single vaccine dose, but also emphasize that asymptomatic individuals might still be carriers/spreaders. |
format |
article |
author |
Rolf Schwarzer Sabine D. Freys Nick Neuwinger Nina Beikert Bettina Eberspächer Anke Edelmann Marta Zuchowski Inga Slothouwer Angela Stein Kathrin Theil Peter Menzel Jörg Hofmann |
author_facet |
Rolf Schwarzer Sabine D. Freys Nick Neuwinger Nina Beikert Bettina Eberspächer Anke Edelmann Marta Zuchowski Inga Slothouwer Angela Stein Kathrin Theil Peter Menzel Jörg Hofmann |
author_sort |
Rolf Schwarzer |
title |
A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany |
title_short |
A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany |
title_full |
A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany |
title_fullStr |
A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany |
title_full_unstemmed |
A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany |
title_sort |
single dose of the biontech/pfizer bnt162b2 vaccine protected elderly residents from severe covid‐19 during a sars‐coronavirus‐2 outbreak in a senior citizen home in germany |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/9d4c59a316a74985af8e11064f6b7dd4 |
work_keys_str_mv |
AT rolfschwarzer asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT sabinedfreys asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT nickneuwinger asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT ninabeikert asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT bettinaeberspacher asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT ankeedelmann asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT martazuchowski asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT ingaslothouwer asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT angelastein asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT kathrintheil asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT petermenzel asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT jorghofmann asingledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT rolfschwarzer singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT sabinedfreys singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT nickneuwinger singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT ninabeikert singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT bettinaeberspacher singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT ankeedelmann singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT martazuchowski singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT ingaslothouwer singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT angelastein singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT kathrintheil singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT petermenzel singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany AT jorghofmann singledoseofthebiontechpfizerbnt162b2vaccineprotectedelderlyresidentsfromseverecovid19duringasarscoronavirus2outbreakinaseniorcitizenhomeingermany |
_version_ |
1718430332448931840 |